Clinic Doses of Doxorubicin Essay Discussion Paper

A. Check lab values from four weeks ago:

Checking lab values from four weeks ago would be irrelevant when administering the fourth doxorubicin dose. While lab values should be checked more frequently than every four weeks during chemotherapy treatment, results from four weeks ago would not provide relevant information about the patient’s current status.

B. Start a peripheral IV and get pump ready

Before administering the fourth dose of doxorubicin, a peripheral IV should be started and the pump should be ready. Doxorubicin is typically administered intravenously, so the nurse must ensure that the IV access is set up and the pump is calibrated and ready to use.

ORDER A PLAGIARISM-FREE PAPER HERE

C. Check pulmonary function test results

Checking the results of pulmonary function tests would be irrelevant when administering the fourth dose of doxorubicin. While some chemotherapy drugs can cause pulmonary toxicity, doxorubicin does not appear to cause significant pulmonary toxicity.

D. Verify the cumulative lifetime do

Before administering the fourth dose, it is critical to confirm the cumulative lifetime dose of doxorubicin. Doxorubicin is a chemotherapy drug with a cumulative dose limit to reduce the risk of cardiotoxicity, which can affect the heart muscle. The cumulative lifetime dose limit for doxorubicin is usually based on the patient’s body surface area, and before administering the fourth dose, the nurse should ensure that the patient has not exceeded the safe limit.

A patient presents to the clinic for the fourth of six doses of doxorubicin. The nurse knows to:-

Verify the cumulative lifetime do